Literature DB >> 10091616

Worsening of levodopa-induced dyskinesias by motor and mental tasks.

F Durif1, M Vidailhet, B Debilly, Y Agid.   

Abstract

Ten patients who had Parkinson's disease with disabling dyskinesia were included in this study to evaluate the role of mental (mental calculation) and motor (flexion/extension of right fingers, flexion/extension of left fingers, flexion/extension of the neck, speaking aloud) tasks on the worsening of peak-dose dyskinesia following administration of an effective single dose of apomorphine. Compared with the score at rest (1.3+/-0.3), a significant aggravation of the dyskinesia score was observed during speaking aloud (5.2+/-1.1, p<0.05), movements of right (4.5+/-1.0, p<0.05) and left (3.7+/-0.8, p<0.05) fingers, movements of the neck (5.1+/-1.0, p<0.05), and mental calculation (3.1+/-1.0, p<0.05). These results suggest that activation tasks such as "speaking aloud" could be used for objective assessment of dyskinesia severity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091616     DOI: 10.1002/1531-8257(199903)14:2<242::aid-mds1007>3.0.co;2-w

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

1.  Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease.

Authors:  F Durif; J J Lemaire; B Debilly; G Dordain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease.

Authors:  Sarah Lemieux; Mehrdad Ghassemi; Mandar Jog; Roderick Edwards; Christian Duval
Journal:  Exp Brain Res       Date:  2006-08-30       Impact factor: 1.972

3.  Objective measurement of dyskinesia in Parkinson's disease using a force plate.

Authors:  Kathryn A Chung; Brenna M Lobb; John G Nutt; James McNames; Fay Horak
Journal:  Mov Disord       Date:  2010-04-15       Impact factor: 10.338

4.  Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.

Authors:  R Katzenschlager; A Evans; A Manson; P N Patsalos; N Ratnaraj; H Watt; L Timmermann; R Van der Giessen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

5.  Stress and mindfulness in Parkinson's disease - a survey in 5000 patients.

Authors:  Anouk van der Heide; Anne E M Speckens; Marjan J Meinders; Liana S Rosenthal; Bastiaan R Bloem; Rick C Helmich
Journal:  NPJ Parkinsons Dis       Date:  2021-01-18

6.  Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's Disease.

Authors:  Kathryn A Chung; Brenna M Lobb; Charles F Murchison; Martina Mancini; Penelope Hogarth; John G Nutt
Journal:  Mov Disord Clin Pract       Date:  2018-03-02

7.  Excessive Sensitivity to Uncertain Visual Input in L-DOPA-Induced Dyskinesias in Parkinson's Disease: Further Implications for Cerebellar Involvement.

Authors:  James K R Stevenson; Chonho Lee; Bu-Sung Lee; Pouria Talebifard; Edna Ty; Kristina Aseeva; Meeko M K Oishi; Martin J McKeown
Journal:  Front Neurol       Date:  2014-02-04       Impact factor: 4.003

8.  The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson's Disease.

Authors:  Anouk van der Heide; Marjan J Meinders; Bastiaan R Bloem; Rick C Helmich
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  Stress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying Mechanisms.

Authors:  Anouk van der Heide; Marjan J Meinders; Anne E M Speckens; Tessa F Peerbolte; Bastiaan R Bloem; Rick C Helmich
Journal:  Mov Disord       Date:  2020-10-23       Impact factor: 10.338

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.